Your session is about to expire
← Back to Search
Part A, Active dose A and Low body surface area for Psoriasis
Study Summary
This trial tests a new topical ointment to see if it is safe, well-tolerated, and affects the body in expected ways.
- Psoriasis
- Atopic Dermatitis
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- Group 1: Part A, Active dose A and Low body surface area
- Group 2: Part A, Active dose A and Middle body surface area
- Group 3: Part A, Active dose A and High body surface area
- Group 4: Part A, Active dose B and Low body surface area
- Group 5: Part A, Active dose B and Middle body surface area
- Group 6: Part A, Active dose B and High body surface area
- Group 7: Part A, Placebo and Low body surface area
- Group 8: Part A, Placebo and Middle body surface area
- Group 9: Part A, Placebo and High body surface area
- Group 10: Part B, Active dose A and High body surface area
- Group 11: Part B, Active dose B and High body surface area
- Group 12: Part B, Placebo and High body surface area
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What are the eligibility criteria for enrolling in this trial?
"This study seeks 54 participants suffering from atopic dermatitis between the age of majority and 65."
Does the criteria for this medical experiment preclude individuals over 85 years of age?
"Participants of this medical trial must be between 18 and 65 years old to meet the study's eligibility requirements."
What has been determined regarding the safety of Part A, Active dose A and High body surface area for individuals?
"Power's team gave Part A, Active dose A and High body surface area a score of 1 due to the minimal data available in relation to its efficacy and safety. This is only Phase 1 trial after all."
How many participants is this experiment enrolling?
"Affirmative. Analysis of the data hosted on clinicaltrials.gov reveals that this medical trial is presently enrolling participants, beginning from April 8th 2023 and last updated May 24th 2023. 54 patients are being recruited across a single site."
Is this study looking for new participants at present?
"Indeed, the information published on clinicaltrials.gov reflects that this medical study is actively recruiting participants; it was first shared online on April 8th 2023 and updated May 24th of the same year. 54 volunteers are required to complete this trial at one research site."
Share this study with friends
Copy Link
Messenger